212 related articles for article (PubMed ID: 9050026)
1. Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential.
Saxena PR; De Vries P; Wang W; Heiligers JP; Maassen vandenBrink A; Bax WA; Yocca FD
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):295-302. PubMed ID: 9050026
[TBL] [Abstract][Full Text] [Related]
2. BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential.
Saxena PR; De Vries P; Heiligers JP; Bax WA; Maassen VanDenBrink A; Yocca FD
Eur J Pharmacol; 1998 Jun; 351(3):329-39. PubMed ID: 9721025
[TBL] [Abstract][Full Text] [Related]
3. Investigations with GMC2021 in experimental models predictive of antimigraine activity and coronary side-effect potential.
Saxena PR; De Vries P; Heiligers JP; Maassen VanDenBrink A; Bax WA; Barf T; Wikström H
Eur J Pharmacol; 1996 Sep; 312(1):53-62. PubMed ID: 8891578
[TBL] [Abstract][Full Text] [Related]
4. Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity.
Willems E; De Vries P; Heiligers JP; Saxena PR
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):212-9. PubMed ID: 9750007
[TBL] [Abstract][Full Text] [Related]
5. Effects of S20749, a close analogue of sumatriptan, on porcine carotid haemodynamics and human isolated coronary artery.
Saxena PR; Maassen vandenBrink A; Heiligers JP; Scalbert E; Lemaitre BG
Pharmacol Toxicol; 1996 Oct; 79(4):199-204. PubMed ID: 8899861
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses.
De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR
Br J Pharmacol; 1999 May; 127(2):405-12. PubMed ID: 10385240
[TBL] [Abstract][Full Text] [Related]
7. The antimigraine agent alniditan selectively constricts porcine carotid arteriovenous anastomoses via 5-HT1B/1D receptors.
De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR
Eur J Pharmacol; 1998 Jun; 351(2):193-201. PubMed ID: 9687003
[TBL] [Abstract][Full Text] [Related]
8. Bovine isolated middle cerebral artery contractions to antimigraine drugs.
Roon KI; Maassen Van Den Brink A; Ferrari MD; Saxena PR
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):591-6. PubMed ID: 10598799
[TBL] [Abstract][Full Text] [Related]
9. Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.
den Boer MO; Villalón CM; Heiligers JP; Humphrey PP; Saxena PR
Br J Pharmacol; 1991 Feb; 102(2):323-30. PubMed ID: 1849764
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
12. Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.
den Boer MO; Heiligers JP; Saxena PR
Br J Pharmacol; 1991 Sep; 104(1):183-9. PubMed ID: 1664762
[TBL] [Abstract][Full Text] [Related]
13. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs.
Parsons AA; Parker SG; Raval P; Campbell CA; Lewis VA; Griffiths R; Hunter AJ; Hamilton TC; King FD
J Cardiovasc Pharmacol; 1997 Jul; 30(1):136-41. PubMed ID: 9268233
[TBL] [Abstract][Full Text] [Related]
15. Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries.
van den Broek RW; MaassenVanDenBrink A; Mulder PG; Bogers AJ; Avezaat CJ; John GW; Saxena PR
Eur J Pharmacol; 2002 May; 443(1-3):125-32. PubMed ID: 12044802
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.
den Boer MO; Somers JA; Saxena PR
Br J Pharmacol; 1992 Oct; 107(2):577-83. PubMed ID: 1330188
[TBL] [Abstract][Full Text] [Related]
17. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
Gupta P; Butler P; Shepperson NB; McHarg A
Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
[TBL] [Abstract][Full Text] [Related]
18. Coronary side-effect potential of current and prospective antimigraine drugs.
MaassenVanDenBrink A; Reekers M; Bax WA; Ferrari MD; Saxena PR
Circulation; 1998 Jul; 98(1):25-30. PubMed ID: 9665056
[TBL] [Abstract][Full Text] [Related]
19. Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
Muñoz-Islas E; Gupta S; Jiménez-Mena LR; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM
Br J Pharmacol; 2006 Sep; 149(1):82-91. PubMed ID: 16880765
[TBL] [Abstract][Full Text] [Related]
20. Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.
Dahlöf CG; Falk L; Risenfors M; Lewis CP
Cephalalgia; 1998 Oct; 18(8):546-51. PubMed ID: 9827246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
